Reactions Weekly

, Volume 1658, Issue 1, pp 348–348 | Cite as

Nilotinib

Various toxicities: 9 case reports
Case report
  • 20 Downloads

Reference

  1. Sacha T, et al. Quality of Life and Adherence to Therapy in Patients With Chronic Myeloid Leukemia Treated With Nilotinib as a Second-Line Therapy: A Multicenter Prospective Observational Study. Clinical Lymphoma, Myeloma & Leukemia 17: 283-295, No. 5, May 2017. Available from: URL: http://doi.org/10.1016/j.clml.2017.01.001 - PolandCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Personalised recommendations